COVID-19 Vaccination Program Data Analysis Based on Regional Status and Day Type: A Study from West Java Province, Indonesia

Ilhami, Putri Adilla; Adisasmita, Mulya Nurmansyah; Agustian, Dwi; Sujatmiko, Budi

doi:10.3390/healthcare11050772

Cited by 3 publications

(7 citation statements)

References 40 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

Section: Discussionmentioning

confidence: 99%

“…Indonesian people's perspectives of booster programmes show the dominance of positive sentiments towards vaccine boosters compared with negative sentiments [5,16]. A study found a significant difference in vaccination coverage and vaccination timing between cities and rural areas [5,16]. Because of national mandatory regulations and the demand for COVID-19 booster vaccinations in Indonesia, PT Bio Farma has developed a COVID-19 vaccine to help accomplish target vaccination for all populations globally, particularly in Indonesia [11,12].…”

Section: Discussionmentioning

confidence: 99%

“…According to the WHO target product profile for COVID-19 vaccines, the vaccine in development should be indicated for active immunisation in all populations, including the elderly, in areas with an ongoing COVID-19 outbreak, and should be used in conjunction with other control measures to curtail or end such an outbreak [1][2][3][4]. The investment in SARS-CoV-2 vaccine development will contribute to the stabilisation of the supply of safe and affordable COVID-19 vaccines in the global market, particularly for distribution in low-and middle-income countries [2,[4][5][6]. The COVID-19 pandemic and the precipitously increased number of deaths worldwide necessitate the urgent development of SARS-CoV-2 vaccines, hence requiring a new pandemic paradigm [1,[3][4][5].…”

Section: Introductionmentioning

confidence: 99%

“…The investment in SARS-CoV-2 vaccine development will contribute to the stabilisation of the supply of safe and affordable COVID-19 vaccines in the global market, particularly for distribution in low-and middle-income countries [2,[4][5][6]. The COVID-19 pandemic and the precipitously increased number of deaths worldwide necessitate the urgent development of SARS-CoV-2 vaccines, hence requiring a new pandemic paradigm [1,[3][4][5].…”

Section: Introductionmentioning

confidence: 99%

“…In Indonesia, 30 clinical trials for COVID-19 vaccines were conducted, and 13 vaccines were subsequently approved for use [5][6][7][8][9]. The national vaccination campaign for COVID-19 was introduced in January 2021, prioritising healthcare workers in the first stage and continuing to essential public service workers and older people [5,6,10]. Indonesia targeted to vaccinate at least 80% of its population by the end of 2023.…”

Section: Introductionmentioning

confidence: 99%

See 4 more Smart Citations

Immunogenicity and Safety of SARS-CoV-2 Protein Subunit Recombinant Vaccine (IndoVac®) as a Booster Dose against COVID-19 in Indonesian Adults

Rusmil,

Fadlyana,

Girsang

et al. 2024

Vaccines

View full text Add to dashboard Cite

According to the WHO target product profile for COVID-19 vaccines, the vaccine in development should be indicated for active immunisation in all populations. Therefore, PT Bio Farma developed a candidate vaccine in a subunit protein recombinant platform to help overcome the issue. This trial was an observer-blind, randomised, prospective intervention study. This study targeted individuals who had received complete primary doses of the authorised/approved COVID-19 vaccine. The groups were divided into the primary inactivated vaccine (CoronaVac®) group, the primary viral vector vaccine (ChAdOx1) group, and the primary mRNA vaccine (BNT162b2) group that received the recombinant protein (IndoVac®). The groups were compared with the control and primary mRNA vaccine (BNT162b2). The participants enrolled in the study were from two primary care centres in Bandung City and three primary care centres in Denpasar City. A total of 696 participants were enrolled from 1 September to 31 October 2022. The demographic characteristics of the all-vaccine group showed a uniform distribution. The results showed that, compared with the control, the investigational product had inferior effectiveness 14 days after the booster dose was administered. However, 28 days after the booster dose, the investigational product exhibited non-inferior effectiveness compared with the primary groups that received CoronaVac® (GMR 0.76 (0.57–0.99)) and ChAdOx1 (GMR 0.72 (0.56–59.93)), but the BNT162b2 group (GMR 0.61 (0.39–0.94)) was inferior to the control. At 12 months follow-up after the booster dose, three serious adverse events (SAEs) were reported in three participants, with causality not correlated with the investigated products. Neither AEs of special interest nor severe COVID-19 cases were reported throughout the follow-up period; thus, the IndoVac® vaccine as a booster was immunogenic and safe. Until the 6-month follow-up after the booster dose, the IndoVac® vaccine was well tolerated and all reported AEs resolved. This vaccine is registered and can be included in the immunisation programme.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 3 more Smart Citations

Immunogenicity and Safety of SARS-CoV-2 Protein Subunit Recombinant Vaccine (IndoVac®) as a Booster Dose against COVID-19 in Indonesian Adults

Rusmil,

Fadlyana,

Girsang

et al. 2024

Vaccines

View full text Add to dashboard Cite

show abstract

Correlation of public mobility and Covid-19 incidence in Indonesia during six phases of restriction policy implementation

Sujatmiko,

Alhayati,

Pratiwi

et al. 2024

E3S Web of Conf.

Self Cite

View full text Add to dashboard Cite

Public mobility is considered one of the factors thought to impact the transmission of SARS-CoV2. The Indonesian government has imposed six mobility restriction policies since the beginning of the COVID-19 pandemic to cope this situation, however there has been no comprehensive evaluation of this program. This study aimed to examine the correlation between mobility and the incidence of COVID-19 during the implementation of this policy in Indonesia. Secondary data on public mobility, acquired through the Google Community Mobility Reports, and data on COVID-19 new cases, recorded on the COVID Task Force website, were utilized from 2 March 2020 to 20 July 2021.The analysis in this study was carried out using the Pearson correlation test with an alternative Spearman correlation test. The result reported a positive correlation between COVID-19 cases and mobility in certain places, such as in Grocery Store and Transit Station (r = 0.75; p-value <0.001; r = 0.62 p-value <0.001) while there was negative correlation in residential area (r= - 0.276 p-value < 0.001). Public mobility is found to be correlated with an increase in COVID-19 cases during the six phases of restriction policy implementation. In conclusion, regulating public mobility is important to minimize the risk of COVID-19 transmission.

show abstract

Program Pemeriksaan Fungsi Paru dengan Peak Flow Meter di SD Taruna Karya 153, Kecamatan Cibiru

Chandra,

Gustifante,

Ciptady

et al. 2024

Creat J. Cumn Enga

View full text Add to dashboard Cite

ABSTRAK Penyakit pernapasan masih banyak terjadi terutama pada anak anak. Hal ini mencakup asma, alergi, ataupun infeksi saluran pernapasan. Upaya penanggulangan masalah khususnya melalui deteksi dini menjadi hal yang krusial dalam meminimalisasi bahaya yang ditimbulkan penyakit pernapasan. Peak flow meter (PFM) merupakan merupakan salah satu metode pengukuran sederhana yang efektif dan efisien untuk mengukur fungsi paru. Pengukuran peak expiratory flow rate (PEFR) dengan PFM dapat membantu mendeteksi asma serta gangguan fungsi paru lainnya. Tujuan dari pengabdian ini adalah untuk mengukur dan menggambarkan fungsi paru siswa-siswi kelas 4-6 di SD Taruna Karya 153. Metode dari pengabdian ini adalah dengan pemeriksaan langsung pada murid-murid menggunakan alat antropometri yaitu timbangan berat badan digital, stadiometer, dan pemeriksaan fungsi paru dengan menggunakan PFM. Hasil dari kegiatan ini dari 240 siswa-siswi kelas 4-6 SD Taruna Karya 153 yang mengikuti pemeriksaan, rata-rata PEFR yang diukur adalah 205,83±71,74 dengan rincian PEFR siswa 234,57±70,42 dan siswi 178,28±59,76. Kesimpulannya siswa-siswi SD kelas 4-6 memiliki tingkat IMT pada batas normal, tetapi sebagian besar memiliki PEFR yang relatif rendah dibandingkan dengan pengukuran PEFR anak di Thailand, Tebing Tinggi, dan Medan. Hal ini mungkin disebabkan karena perbedaan ras, genetik, geografik, etnis, dan umur. Selain itu, kondisi kesehatan sebagian partisipan yang mengindikasikan gejala gangguan pernapasan ataupun kondisi lingkungan seperti polusi domestik ataupun kebiasaan merokok anggota keluarga di lingkungan tempat tinggal juga menjadi salah satu faktor yang mempengaruhi rendahnya hasil pengukuran fungsi paru. Saran pemeriksaaan fungsi paru dapat dilakukan secara berkala untuk memantau kondisi kesehatan peserta didik sejak dini. Kata Kunci: Anak, Pemeriksaan, Peak Flow Meter, Fungsi paru ABSTRACT Respiratory diseases are still common, especially in children. This includes asthma, allergies, or respiratory tract infections. Efforts to overcome the problem, especially through early detection, were crucial in minimizing the dangers posed by respiratory diseases. Peak flow meter (PFM) is a simple measurement method that is effective and efficient for measuring lung function. Measuring peak expiratory flow rate (PEFR) with a PFM can help detect asthma and other lung function disorders. This service aims to measure and describe the lung function of students in grades 4-6 at Taruna Karya 153 Elementary School. The method used in this service was to directly examine the students using anthropometric tools, namely digital weight scales and stadiometers, and lung function measurement using a PFM. From 240 students in grades 4-6 of Taruna Karya 153 Elementary School who took part in the examination, the overall average PEFR measured was 205.83±71.74 with average PEFR for male students 234.57±70.42 and female students 178.28±59.76. In conclusion, elementary school students in grades 4-6 have BMI levels within normal limits, but most have relatively low PEFR compared to the PEFR measurements of children in Thailand, Tebing Tinggi and Medan. This might be due to differences in race, genetics, geography, ethnicity, and age. Apart from that, the health condition of some participants which indicated symptoms of respiratory problems or environmental conditions such as domestic pollution or smoking habits were also factors that influenced low lung function measurement results. It is recommended that lung function checks be carried out periodically to monitor students' health conditions from an early age. Keywords: Children, Measurement, Peak Flow Meter, Lung Function

show abstract

COVID-19 Vaccination Program Data Analysis Based on Regional Status and Day Type: A Study from West Java Province, Indonesia

Cited by 3 publications

References 40 publications

Immunogenicity and Safety of SARS-CoV-2 Protein Subunit Recombinant Vaccine (IndoVac®) as a Booster Dose against COVID-19 in Indonesian Adults

Immunogenicity and Safety of SARS-CoV-2 Protein Subunit Recombinant Vaccine (IndoVac®) as a Booster Dose against COVID-19 in Indonesian Adults

Correlation of public mobility and Covid-19 incidence in Indonesia during six phases of restriction policy implementation

Program Pemeriksaan Fungsi Paru dengan Peak Flow Meter di SD Taruna Karya 153, Kecamatan Cibiru

Contact Info

Product

Resources

About